Skip to main content
NOVAVAX INC logo

NOVAVAX INC — Investor Relations & Filings

Ticker · NVAX ISIN · US6700024010 LEI · 529900J4GJHPEPQ23205 US Manufacturing
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2020-12-09 Director's Dealing
Country US United States of America
Listing US NVAX

About NOVAVAX INC

https://www.novavax.com/?locale=US

Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.

Recent filings

Filing Released Lang Actions
FORM 3 SUBMISSION
Director's Dealing
2020-12-09 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated December 5, 2020, for Novavax, Inc. The key content is the appointment of a new director, Margaret G. Mcglynn, to the Board of Directors. The document details the increase in board size, the appointment, terms, and related indemnification agreement. There is no financial data or earnings information, nor is it a report or presentation. The primary focus is on a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document length is 5527 characters, which is sufficient to contain substantive information about the appointment, not just a brief announcement. Therefore, the correct classification is MANG with high confidence.
2020-12-09 English
FORM 4 SUBMISSION
Director's Dealing
2020-12-08 English
FORM 4 SUBMISSION
Director's Dealing
2020-11-18 English
FORM 4 SUBMISSION
Director's Dealing
2020-11-18 English
FORM 3 SUBMISSION
Director's Dealing
2020-11-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.